Patient Advocay in Rheumatology - A Patient Story

Keck School of Medicine of USC

C. Ames

Dermatologic Manifestations in Rheumatic Diseases

Saakshi Khattri

New 2022 ASAS/EULAR Recommendations on the Management of Axial Spond…

RheumNow

S. Ramiro

High Level View of the Approach to Psoriatic Disease Treatment

Masterclasses in Dermatology

J. Merola

PsA for the Dermatologist

Masterclasses in Dermatology

J. Merola, A. Gottlieb

The Window of Opportunity: Blockbuster Drugs, Opioids in Rheumatolog…

RheumNow

J. Cush

Sex Matters: Gender Differences in PsA Outcomes & Management

RheumNow

L. Eder

Diagnosing Psoriatic Arthritis for the Dermatologist: Making a Diffe…

Masterclasses in Dermatology

J. Merola, A. Gottlieb

2022 GRAPPA Treatment Recommendations

Laura Coates

GRAPPA 2024 Debate- Managing MSK Symptoms in PsO Patients: Who Shoul…

GRAPPA - Group for Research and Assessment of Psoriasis and Psoriatic Arthritis

F. Proft

ACR Convergence 2023 Highlights: Two Studies: TAK-279 (Tyk2) in PsA …

RheumNow

G. Valenzuela

EULAR® 2024 Insights: Reasons for Non-response to Treatments in Pati…

EULAR® 2024 Insights

F. Coşan

Enthesitis & Dactylitis Management

RheumNow

A. Kavanaugh

EULAR® 2024 Insights: Chronic Kidney Disease in Patients with Psoria…

EULAR® 2024 Insights

D. Gladman

Inflammatory Arthritis: What Is It?

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

Long COVID for the Rheumatologist

Cleveland Clinic Rheumatology

L. Calabrese

ACR Convergence 2023 Highlights: Myositis Pearls for Diagnosis and M…

Highlights from ACR Convergence 2023

L. Christopher-Stine

EULAR 2023 Insights: Is Methotrexate Safe for Men With an Immune-Med…

EULAR 2023 Insights

L. Fernando Perez-Garcia

Interdisciplinary Approaches to Psoriatic Disease: Combining Clinics…

Joseph Merola

A Year in Review: What Was New in Psoriasis Treatment in 2021 and Wh…

Joseph Merola